Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19
Clinical trial NCT04836260 · UNKNOWN
Trial details
- NCT number
- NCT04836260
- Sponsor
- University Hospital, Geneva
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-08
- Primary completion
- 2021-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.